DR-01-ONC-001 - Virginia Cancer Specialists

Trial ID DR-01-ONC-001

Sponsor ID Dren Bio

A Multicenter, Open-Label, First-in-Human, Multiple Expansion Cohort, Phase 1/2 Study to Evaluate the Safety and Efficacy of DR-01 in Adult Subjects with Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Principal Investigator

Alexander I. Spira, MD, PhD, FACP

1 Location

Leukemia

Lymphoma

Locations

Fairfax Office

Learn More About This Trial

Name*
First Last
Diagnosis / Trial Interested In*
Email*
Enter Email Confirm Email
Comments
Phone
CAPTCHA

Other Relevant Trials

Trial ID ADCT-402-105

Sponsor ID LOTIS-7

A Phase 1b Open-Label Study to Evaluate the Safety and Anti-Cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-Cancer Agents in Patients with Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma

Principal Investigator

Mitul Gandhi, MD

1 Location

Lymphoma

Trial ID SLSG18-301

Sponsor ID Sellas

A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator’s Choice of Best Available Therapy in Subjects with Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy